Price-to-Sales Ratio for Cannabis Stocks

The Price-to-Sales ratio (P/S) is the most commonly used valuation metric for cannabis stocks, and understanding it is essential for any cannabis investor. P/S is calculated by dividing a company's market capitalization by its trailing twelve months (TTM) of revenue, or equivalently, dividing the share price by revenue per share.

P/S is preferred over traditional metrics like Price-to-Earnings (P/E) in the cannabis industry because most cannabis companies are not yet profitable. Section 280E taxation, high growth-phase spending, and ongoing capital investments mean that net income is negative or unreliable for many operators. Since P/S uses revenue rather than earnings, it provides a usable valuation metric for unprofitable growth companies.

For cannabis stocks, a low P/S ratio may indicate a value opportunity, while a high P/S suggests the market expects strong future growth. However, context matters enormously. A P/S of 1.0x for a slow-growing company might be expensive, while 3.0x for a rapidly growing MSO might be reasonable.

As of recent market conditions, cannabis stocks generally trade at P/S ratios between 0.3x and 3.0x, well below the peak valuations of 10x or higher seen during the 2021 speculative boom. MSOs tend to trade at lower P/S ratios than Canadian LPs when adjusted for growth, partly due to OTC liquidity discounts and 280E taxation impacts.

When using P/S to compare cannabis companies, ensure you are comparing within similar subcategories — MSOs to MSOs, LPs to LPs, ancillary companies to ancillary companies. Also consider revenue quality: recurring revenue from retail operations is generally valued higher than volatile wholesale revenue. Revenue growth rate is an important companion metric — a company growing revenue at 30% annually deserves a higher P/S than one growing at 5%.

Other useful valuation metrics for cannabis include Enterprise Value to Revenue (EV/Revenue), which accounts for debt and cash, and Enterprise Value to EBITDA (EV/EBITDA) for companies that have achieved positive EBITDA. As the industry matures and more companies reach profitability, traditional P/E ratios will become increasingly relevant.

Frequently Asked Questions

What is a good P/S ratio for a cannabis stock?

Cannabis P/S ratios typically range from 0.3x to 3.0x in current markets. A 'good' ratio depends on the company's growth rate, profitability trajectory, and sector. Fast-growing MSOs may warrant higher ratios than slow-growing LPs. Compare within peer groups rather than using absolute targets.

Why is P/S used instead of P/E for cannabis stocks?

Most cannabis companies are not yet profitable due to 280E taxation, growth-phase spending, and capital investments, making P/E ratios meaningless or misleading. P/S uses revenue instead of earnings, providing a usable valuation metric for unprofitable growth companies.

How do I calculate the P/S ratio for a cannabis stock?

Divide the company's market capitalization by its trailing twelve months (TTM) of revenue. For example, if a company has a $500M market cap and $250M in TTM revenue, its P/S ratio is 2.0x. You can find market cap and revenue data on Cannabismarketcap stock pages.

Related Stocks

Related Terms